Digital dosing and the future of therapeutic drug monitoring: insights from the 23rd IATDMCT congress
When it comes to therapeutics, the core clinical challenge is often distilled down to a critical question: how much drug, and for how long? For too long, the aspiration toward truly personalised medicine has been constrained by the limitations of static, one-size-fits-all dosing and outdated pharmacokinetic (PK) models – a rigid system ill-equipped for advanced […]





